These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

510 related items for PubMed ID: 31984480

  • 1. Oral Janus kinase inhibitors for maintenance of remission in ulcerative colitis.
    Davies SC, Hussein IM, Nguyen TM, Parker CE, Khanna R, Jairath V.
    Cochrane Database Syst Rev; 2020 Jan 27; 1(1):CD012381. PubMed ID: 31984480
    [Abstract] [Full Text] [Related]

  • 2. Anti-IL-12/23p40 antibodies for maintenance of remission in Crohn's disease.
    Davies SC, Nguyen TM, Parker CE, MacDonald JK, Jairath V, Khanna R.
    Cochrane Database Syst Rev; 2019 Dec 12; 12(12):CD012804. PubMed ID: 31828765
    [Abstract] [Full Text] [Related]

  • 3. Adalimumab for maintenance of remission in Crohn's disease.
    Townsend CM, Nguyen TM, Cepek J, Abbass M, Parker CE, MacDonald JK, Khanna R, Jairath V, Feagan BG.
    Cochrane Database Syst Rev; 2020 May 16; 5(5):CD012877. PubMed ID: 32413933
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Adalimumab for induction of remission in Crohn's disease.
    Abbass M, Cepek J, Parker CE, Nguyen TM, MacDonald JK, Feagan BG, Khanna R, Jairath V.
    Cochrane Database Syst Rev; 2019 Nov 14; 2019(11):. PubMed ID: 31742665
    [Abstract] [Full Text] [Related]

  • 6. Antibiotics for induction and maintenance of remission in Crohn's disease.
    Townsend CM, Parker CE, MacDonald JK, Nguyen TM, Jairath V, Feagan BG, Khanna R.
    Cochrane Database Syst Rev; 2019 Feb 07; 2(2):CD012730. PubMed ID: 30731030
    [Abstract] [Full Text] [Related]

  • 7. Cannabis for the treatment of Crohn's disease.
    Kafil TS, Nguyen TM, MacDonald JK, Chande N.
    Cochrane Database Syst Rev; 2018 Nov 08; 11(11):CD012853. PubMed ID: 30407616
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Fecal transplantation for treatment of inflammatory bowel disease.
    Imdad A, Nicholson MR, Tanner-Smith EE, Zackular JP, Gomez-Duarte OG, Beaulieu DB, Acra S.
    Cochrane Database Syst Rev; 2018 Nov 13; 11(11):CD012774. PubMed ID: 30480772
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Etrolizumab for induction of remission in ulcerative colitis.
    Rosenfeld G, Parker CE, MacDonald JK, Bressler B.
    Cochrane Database Syst Rev; 2015 Dec 02; 2015(12):CD011661. PubMed ID: 26630451
    [Abstract] [Full Text] [Related]

  • 12. Natalizumab for induction of remission in Crohn's disease.
    Nelson SM, Nguyen TM, McDonald JW, MacDonald JK.
    Cochrane Database Syst Rev; 2018 Aug 01; 8(8):CD006097. PubMed ID: 30068022
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Azathioprine and 6-mercaptopurine for maintenance of surgically-induced remission in Crohn's disease.
    Gjuladin-Hellon T, Iheozor-Ejiofor Z, Gordon M, Akobeng AK.
    Cochrane Database Syst Rev; 2019 Aug 06; 8(8):CD010233. PubMed ID: 31425621
    [Abstract] [Full Text] [Related]

  • 15. Azathioprine and 6-mercaptopurine for maintenance of surgically-induced remission in Crohn's disease.
    Gordon M, Taylor K, Akobeng AK, Thomas AG.
    Cochrane Database Syst Rev; 2014 Aug 01; 2014(8):CD010233. PubMed ID: 25081347
    [Abstract] [Full Text] [Related]

  • 16. Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis.
    Feagan BG, Macdonald JK.
    Cochrane Database Syst Rev; 2012 Oct 17; 10():CD000544. PubMed ID: 23076890
    [Abstract] [Full Text] [Related]

  • 17. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K, Williams J, Qi YP, Gutman J, Yeung L, Mai C, Finkelstain J, Mehta S, Pons-Duran C, Menéndez C, Moraleda C, Rogers L, Daniels K, Green P.
    Cochrane Database Syst Rev; 2022 Feb 01; 2(2022):. PubMed ID: 36321557
    [Abstract] [Full Text] [Related]

  • 18. Vedolizumab for induction and maintenance of remission in ulcerative colitis.
    Bickston SJ, Behm BW, Tsoulis DJ, Cheng J, MacDonald JK, Khanna R, Feagan BG.
    Cochrane Database Syst Rev; 2014 Aug 08; 2014(8):CD007571. PubMed ID: 25105240
    [Abstract] [Full Text] [Related]

  • 19. Probiotics for induction of remission in ulcerative colitis.
    Kaur L, Gordon M, Baines PA, Iheozor-Ejiofor Z, Sinopoulou V, Akobeng AK.
    Cochrane Database Syst Rev; 2020 Mar 04; 3(3):CD005573. PubMed ID: 32128795
    [Abstract] [Full Text] [Related]

  • 20. Oral budesonide for induction of remission in ulcerative colitis.
    Sherlock ME, MacDonald JK, Griffiths AM, Steinhart AH, Seow CH.
    Cochrane Database Syst Rev; 2015 Oct 26; 2015(10):CD007698. PubMed ID: 26497719
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.